ID U2AF4_HUMAN Reviewed; 220 AA. AC Q8WU68; A6NKI8; Q56UU3; DT 13-NOV-2007, integrated into UniProtKB/Swiss-Prot. DT 13-NOV-2007, sequence version 2. DT 27-MAR-2024, entry version 184. DE RecName: Full=Splicing factor U2AF 26 kDa subunit; DE AltName: Full=U2 auxiliary factor 26; DE AltName: Full=U2 small nuclear RNA auxiliary factor 1-like protein 4; DE Short=U2AF1-like 4 {ECO:0000250|UniProtKB:Q8BGJ9}; DE AltName: Full=U2(RNU2) small nuclear RNA auxiliary factor 1-like protein 3; DE Short=U2 small nuclear RNA auxiliary factor 1-like protein 3; DE Short=U2AF1-like protein 3; GN Name=U2AF1L4; Synonyms=U2AF1-RS3, U2AF1L3; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND TISSUE SPECIFICITY. RX PubMed=17312947; DOI=10.1080/10425170600807744; RA Chen F., Ji C., Dou T., Zheng N., Qiu R., Peng J., Fang W., Feng C., RA Xie Y., Mao Y.; RT "Cloning and characterization of a novel splice variant of human U2AF1L3 RT gene."; RL DNA Seq. 17:282-286(2006). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=15057824; DOI=10.1038/nature02399; RA Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E., RA Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A., RA Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S., RA Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A., RA Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J., RA Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M., RA Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W., RA Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V., RA Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D., RA McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I., RA Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L., RA Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A., RA She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., RA Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., RA Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E., RA Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M., RA Rubin E.M., Lucas S.M.; RT "The DNA sequence and biology of human chromosome 19."; RL Nature 428:529-535(2004). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3). RC TISSUE=Brain; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [4] RP PROTEIN SEQUENCE OF 2-13, CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT RP ALA-2, AND IDENTIFICATION BY MASS SPECTROMETRY. RC TISSUE=Colon carcinoma; RA Bienvenut W.V., Zebisch A., Kolch W.; RL Submitted (OCT-2008) to UniProtKB. CC -!- FUNCTION: RNA-binding protein that function as a pre-mRNA splicing CC factor. Plays a critical role in both constitutive and enhancer- CC dependent splicing by mediating protein-protein interactions and CC protein-RNA interactions required for accurate 3'-splice site CC selection. Acts by enhancing the binding of U2AF2 to weak pyrimidine CC tracts. Also participates in the regulation of alternative pre-mRNA CC splicing. Activates exon 5 skipping of PTPRC during T-cell activation; CC an event reversed by GFI1. Binds to RNA at the AG dinucleotide at the CC 3'-splice site (By similarity). Shows a preference for AGC or AGA (By CC similarity). {ECO:0000250|UniProtKB:Q8BGJ9}. CC -!- SUBUNIT: Interacts with GFI1, U2AF2 and C1QBP. CC {ECO:0000250|UniProtKB:Q8BGJ9}. CC -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q8BGJ9}. Nucleus CC speckle {ECO:0000250|UniProtKB:Q8BGJ9}. Cytoplasm CC {ECO:0000250|UniProtKB:Q8BGJ9}. Note=Interaction with C1QBP is required CC for the nuclear translocation. Displays active nucleo-cytoplasmic CC shuttling. {ECO:0000250|UniProtKB:Q8BGJ9}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=3; CC Name=1; CC IsoId=Q8WU68-1; Sequence=Displayed; CC Name=2; CC IsoId=Q8WU68-2; Sequence=VSP_029264, VSP_029265; CC Name=3; CC IsoId=Q8WU68-3; Sequence=VSP_029264; CC -!- TISSUE SPECIFICITY: Isoform 2 is widely expressed. Isoform 3 is highly CC expressed in heart, brain and lung, lower expressed in thymus and much CC lower expressed in peripheral blood leukocytes. CC {ECO:0000269|PubMed:17312947}. CC -!- DOMAIN: The second zinc finger in necessary for interaction with GFI1 CC and for alternative pre-mRNA splicing events. {ECO:0000250}. CC -!- DOMAIN: The region 162-220 is essential for the nuclear import of the CC protein in spite of the absence of a nuclear localization signal (NLS). CC This region is essential for the interaction with C1QBP, interaction CC which is required for the nuclear translocation. This region may be CC involved in the localization in nuclear dot-like structures and it also CC confers the ability of nucleo-cytoplasmic shuttling. CC {ECO:0000250|UniProtKB:Q8BGJ9}. CC -!- SIMILARITY: Belongs to the splicing factor SR family. {ECO:0000305}. CC -!- CAUTION: Orthologs of U2AF1L4 do not appear to exist in lower CC eukaryotes, Drosophila, C. elegans, plants, or vertebrates such as CC Xenopus or zebrafish. Existence of circadian and light-inducible CC alternative splicing of U2AF1L4 similar to the mouse in human and rat CC is not yet proven. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AY569437; AAT72770.3; -; mRNA. DR EMBL; AD000671; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; BC021186; AAH21186.1; -; mRNA. DR CCDS; CCDS12473.1; -. [Q8WU68-2] DR CCDS; CCDS42551.1; -. [Q8WU68-3] DR RefSeq; NP_001035515.1; NM_001040425.2. [Q8WU68-3] DR RefSeq; NP_659424.2; NM_144987.3. [Q8WU68-2] DR AlphaFoldDB; Q8WU68; -. DR SMR; Q8WU68; -. DR BioGRID; 128270; 12. DR IntAct; Q8WU68; 10. DR iPTMnet; Q8WU68; -. DR PhosphoSitePlus; Q8WU68; -. DR BioMuta; U2AF1L4; -. DR DMDM; 160358766; -. DR EPD; Q8WU68; -. DR jPOST; Q8WU68; -. DR MassIVE; Q8WU68; -. DR MaxQB; Q8WU68; -. DR PeptideAtlas; Q8WU68; -. DR ProteomicsDB; 74637; -. [Q8WU68-1] DR ProteomicsDB; 74638; -. [Q8WU68-2] DR ProteomicsDB; 74639; -. [Q8WU68-3] DR Pumba; Q8WU68; -. DR Antibodypedia; 29506; 136 antibodies from 25 providers. DR DNASU; 199746; -. DR Ensembl; ENST00000292879.9; ENSP00000292879.4; ENSG00000161265.15. [Q8WU68-2] DR Ensembl; ENST00000378975.8; ENSP00000368258.2; ENSG00000161265.15. [Q8WU68-3] DR Ensembl; ENST00000412391.6; ENSP00000397645.2; ENSG00000161265.15. [Q8WU68-1] DR GeneID; 199746; -. DR KEGG; hsa:199746; -. DR MANE-Select; ENST00000378975.8; ENSP00000368258.2; NM_001040425.3; NP_001035515.1. [Q8WU68-3] DR UCSC; uc002obe.5; human. [Q8WU68-1] DR AGR; HGNC:23020; -. DR CTD; 199746; -. DR DisGeNET; 199746; -. DR GeneCards; U2AF1L4; -. DR HGNC; HGNC:23020; U2AF1L4. DR HPA; ENSG00000161265; Low tissue specificity. DR MIM; 601080; gene. DR neXtProt; NX_Q8WU68; -. DR OpenTargets; ENSG00000161265; -. DR PharmGKB; PA164742763; -. DR VEuPathDB; HostDB:ENSG00000161265; -. DR GeneTree; ENSGT00950000183152; -. DR HOGENOM; CLU_059852_1_0_1; -. DR InParanoid; Q8WU68; -. DR OMA; CENENFH; -. DR OrthoDB; 1967949at2759; -. DR PhylomeDB; Q8WU68; -. DR TreeFam; TF300143; -. DR PathwayCommons; Q8WU68; -. DR Reactome; R-HSA-159236; Transport of Mature mRNA derived from an Intron-Containing Transcript. DR Reactome; R-HSA-72163; mRNA Splicing - Major Pathway. DR Reactome; R-HSA-72187; mRNA 3'-end processing. DR Reactome; R-HSA-73856; RNA Polymerase II Transcription Termination. DR SignaLink; Q8WU68; -. DR BioGRID-ORCS; 199746; 15 hits in 1158 CRISPR screens. DR ChiTaRS; U2AF1L4; human. DR GenomeRNAi; 199746; -. DR Pharos; Q8WU68; Tbio. DR PRO; PR:Q8WU68; -. DR Proteomes; UP000005640; Chromosome 19. DR RNAct; Q8WU68; Protein. DR Bgee; ENSG00000161265; Expressed in left lobe of thyroid gland and 98 other cell types or tissues. DR ExpressionAtlas; Q8WU68; baseline and differential. DR GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell. DR GO; GO:0016607; C:nuclear speck; IEA:UniProtKB-SubCell. DR GO; GO:0005654; C:nucleoplasm; TAS:Reactome. DR GO; GO:0005681; C:spliceosomal complex; IBA:GO_Central. DR GO; GO:0089701; C:U2AF complex; IBA:GO_Central. DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW. DR GO; GO:0030628; F:pre-mRNA 3'-splice site binding; IBA:GO_Central. DR GO; GO:0000398; P:mRNA splicing, via spliceosome; IBA:GO_Central. DR CDD; cd12538; RRM_U2AF35; 1. DR Gene3D; 3.30.70.330; -; 1. DR InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf. DR InterPro; IPR035979; RBD_domain_sf. DR InterPro; IPR000504; RRM_dom. DR InterPro; IPR003954; RRM_dom_euk. DR InterPro; IPR009145; U2AF_small. DR InterPro; IPR000571; Znf_CCCH. DR PANTHER; PTHR12620:SF3; SPLICING FACTOR U2AF 26 KDA SUBUNIT; 1. DR PANTHER; PTHR12620; U2 SNRNP AUXILIARY FACTOR, SMALL SUBUNIT; 1. DR Pfam; PF00076; RRM_1; 1. DR Pfam; PF00642; zf-CCCH; 2. DR PRINTS; PR01848; U2AUXFACTOR. DR SMART; SM00361; RRM_1; 1. DR SMART; SM00356; ZnF_C3H1; 2. DR SUPFAM; SSF54928; RNA-binding domain, RBD; 1. DR PROSITE; PS50102; RRM; 1. DR PROSITE; PS50103; ZF_C3H1; 2. DR Genevisible; Q8WU68; HS. PE 1: Evidence at protein level; KW Acetylation; Alternative splicing; Cytoplasm; Direct protein sequencing; KW Metal-binding; mRNA processing; mRNA splicing; Nucleus; Reference proteome; KW Repeat; RNA-binding; Spliceosome; Zinc; Zinc-finger. FT INIT_MET 1 FT /note="Removed" FT /evidence="ECO:0000269|Ref.4" FT CHAIN 2..220 FT /note="Splicing factor U2AF 26 kDa subunit" FT /id="PRO_0000309740" FT DOMAIN 65..147 FT /note="RRM" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00176" FT ZN_FING 12..40 FT /note="C3H1-type 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00723" FT ZN_FING 149..176 FT /note="C3H1-type 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00723" FT REGION 185..220 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 190..206 FT /note="Basic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOD_RES 2 FT /note="N-acetylalanine" FT /evidence="ECO:0000269|Ref.4" FT VAR_SEQ 45..83 FT /note="Missing (in isoform 2 and isoform 3)" FT /evidence="ECO:0000303|PubMed:15489334, FT ECO:0000303|PubMed:17312947" FT /id="VSP_029264" FT VAR_SEQ 143..220 FT /note="ELSPVTDFRESCCRQYEMGECTRGGFCNFMHLRPISQNLQRQLYGRGPRRRS FT PPRFHTGHHPRERNHRCSPDHWHGRF -> NVPEVASATSCICGPFPRTSRGSSMGGDP FT GAGHPRGSILATIPERGTIGVPLITGMAASEALAPLPFTPNRDRCSWQDLSSKPPSLSC FT PILPRLPGSIM (in isoform 2)" FT /evidence="ECO:0000303|PubMed:17312947" FT /id="VSP_029265" FT CONFLICT 109 FT /note="L -> V (in Ref. 3; AAH21186)" FT /evidence="ECO:0000305" SQ SEQUENCE 220 AA; 25744 MW; 64BA09EEDE3FB093 CRC64; MAEYLASIFG TEKDKVNCSF YFKIGVCRHG DRCSRLHNKP TFSQTIVLLN LYRNPQNTAQ TADGSHCHVS DVEVQEHYDS FFEEVFTELQ EKYGEIEEMN VCDNLGDHLV GNVYVKFRRE EDGERAVAEL SNRWFNGQAV HGELSPVTDF RESCCRQYEM GECTRGGFCN FMHLRPISQN LQRQLYGRGP RRRSPPRFHT GHHPRERNHR CSPDHWHGRF //